What concerns have been raised regarding Covishield's potential side effects
AstraZeneca’s submission in U.K. court nothing new, say doctors over Covishield’s potential to cause blood clots
- Reports of rare cases of blood clots: Some concerns have been raised about Covishield's potential side effect of causing rare blood clots, particularly in combination with low platelet count.
- Evidence suggests low risk: Studies have shown that the risk of blood clots from Covishield is very low, and the benefits of vaccination outweigh the risks.
- Regulatory approval: Covishield has been approved by regulatory authorities in many countries, including the UK's Medicines and Healthcare products Regulatory Agency (MHRA).
- Monitoring and reporting: Health authorities are closely monitoring the vaccine's safety profile and encouraging healthcare providers to report any adverse events for further evaluation.
- Education and awareness: It is important for the public to be aware of the potential side effects of Covishield and consult with healthcare professionals if they have any concerns.
Answered
a year ago